5Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazi- dine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by in hibiting mitochondrial long chain3-ketoacyl coenzyme A thiolase [ J ]. Circ Res,2008,86 ( 5 ) :580 - 588.
6Stanley WC, Marzilli M. Metabolic therapy in the treatment of ische- mic heart disease:the pharmacology of trimetazidine [J]. Fundam Clin Pharmacol,2006,17 (2) : 133 - 145.
7E1-Kady T, E1-Sabban K, Gabaly M, et al. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dys- functional myocardium in ischemic cardiomyopathy: a 24-month study[ J]. Am J Cardiovasc Drags,2005,5(4) :271 -278.
8Kay L,Finelli C,Aussedat J,et al.Improvement of long-term preservation of the isolated arrested rat heart by trimetazidine:Effects on the energy state and mitochondrial function[J].Am J Cardiol,1995,76(6):45B-49B.
9Morin D,Elimadi A,Sapena R,et al.Evidence for the existence of[3H]-trimetazidine binding sites involved in the regulation of the mitochondrial permeability transition pore[J].Br J Pharmacol,1998,123 (7):1385-1394.
